Acute and chronic administration of immunomodulators induces anorexia in Zucker rats

F. Lugarini, B. J. Hrupka, Gary J. Schwartz, C. R. Plata-Salaman, W. Langhans

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

To investigate the possible involvement of leptin signaling in lipopolysaccharide (LPS) anorexia, we compared the anorectic effect of LPS in genetically obese (fa/fa) Zucker rats and in their lean (Fa/?) counterparts. The effects of interleukin-1β (IL-1β) and muramyl dipeptide (MDP) were also tested. LPS [100 μg/kg body weight (BW)], IL-1β (2 μg/kg BW) and MDP (2.2 mg/kg BW) injected intraperitoneally (i.p.) at lights out reduced food intake similarly in obese and lean rats. LPS injection at 500 or 1000 μg/kg BW (i.p.) also reduced food intake and BW similarly in obese and lean rats, but obese regained BW faster than lean rats. LPS (2.45 μg or 9.8 μg/h/rat) administered chronically with i.p. implanted osmotic pumps reduced food intake similarly on experimental day 1, regardless of the genotype. After day 3, the lean rats' anorectic response and recovery were dose-dependent, whereas the anorectic response in obese rats was minimally affected by dose (significant dose effect only on day 3). Again, obese rats regained lost BW faster than lean rats. These results do not support a role for leptin as the sole mediator of anorexia induced by bacterial products (LPS and MDP) and IL-1β.

Original languageEnglish (US)
Pages (from-to)165-173
Number of pages9
JournalPhysiology and Behavior
Volume84
Issue number1
DOIs
StatePublished - Jan 31 2005
Externally publishedYes

Fingerprint

Zucker Rats
Immunologic Factors
Anorexia
Lipopolysaccharides
Body Weight
Acetylmuramyl-Alanyl-Isoglutamine
Appetite Depressants
Interleukin-1
Eating
Leptin
Interleukin-2
Genotype
Light
Injections

Keywords

  • Anorexia
  • Body weight
  • Cytokines
  • Feeding
  • Food intake
  • Genotype
  • Interleukin
  • Leptin
  • Obesity

ASJC Scopus subject areas

  • Behavioral Neuroscience
  • Physiology (medical)

Cite this

Acute and chronic administration of immunomodulators induces anorexia in Zucker rats. / Lugarini, F.; Hrupka, B. J.; Schwartz, Gary J.; Plata-Salaman, C. R.; Langhans, W.

In: Physiology and Behavior, Vol. 84, No. 1, 31.01.2005, p. 165-173.

Research output: Contribution to journalArticle

Lugarini, F. ; Hrupka, B. J. ; Schwartz, Gary J. ; Plata-Salaman, C. R. ; Langhans, W. / Acute and chronic administration of immunomodulators induces anorexia in Zucker rats. In: Physiology and Behavior. 2005 ; Vol. 84, No. 1. pp. 165-173.
@article{7c86b69ad211430888adba85b59d2f24,
title = "Acute and chronic administration of immunomodulators induces anorexia in Zucker rats",
abstract = "To investigate the possible involvement of leptin signaling in lipopolysaccharide (LPS) anorexia, we compared the anorectic effect of LPS in genetically obese (fa/fa) Zucker rats and in their lean (Fa/?) counterparts. The effects of interleukin-1β (IL-1β) and muramyl dipeptide (MDP) were also tested. LPS [100 μg/kg body weight (BW)], IL-1β (2 μg/kg BW) and MDP (2.2 mg/kg BW) injected intraperitoneally (i.p.) at lights out reduced food intake similarly in obese and lean rats. LPS injection at 500 or 1000 μg/kg BW (i.p.) also reduced food intake and BW similarly in obese and lean rats, but obese regained BW faster than lean rats. LPS (2.45 μg or 9.8 μg/h/rat) administered chronically with i.p. implanted osmotic pumps reduced food intake similarly on experimental day 1, regardless of the genotype. After day 3, the lean rats' anorectic response and recovery were dose-dependent, whereas the anorectic response in obese rats was minimally affected by dose (significant dose effect only on day 3). Again, obese rats regained lost BW faster than lean rats. These results do not support a role for leptin as the sole mediator of anorexia induced by bacterial products (LPS and MDP) and IL-1β.",
keywords = "Anorexia, Body weight, Cytokines, Feeding, Food intake, Genotype, Interleukin, Leptin, Obesity",
author = "F. Lugarini and Hrupka, {B. J.} and Schwartz, {Gary J.} and Plata-Salaman, {C. R.} and W. Langhans",
year = "2005",
month = "1",
day = "31",
doi = "10.1016/j.physbeh.2004.11.003",
language = "English (US)",
volume = "84",
pages = "165--173",
journal = "Physiology and Behavior",
issn = "0031-9384",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Acute and chronic administration of immunomodulators induces anorexia in Zucker rats

AU - Lugarini, F.

AU - Hrupka, B. J.

AU - Schwartz, Gary J.

AU - Plata-Salaman, C. R.

AU - Langhans, W.

PY - 2005/1/31

Y1 - 2005/1/31

N2 - To investigate the possible involvement of leptin signaling in lipopolysaccharide (LPS) anorexia, we compared the anorectic effect of LPS in genetically obese (fa/fa) Zucker rats and in their lean (Fa/?) counterparts. The effects of interleukin-1β (IL-1β) and muramyl dipeptide (MDP) were also tested. LPS [100 μg/kg body weight (BW)], IL-1β (2 μg/kg BW) and MDP (2.2 mg/kg BW) injected intraperitoneally (i.p.) at lights out reduced food intake similarly in obese and lean rats. LPS injection at 500 or 1000 μg/kg BW (i.p.) also reduced food intake and BW similarly in obese and lean rats, but obese regained BW faster than lean rats. LPS (2.45 μg or 9.8 μg/h/rat) administered chronically with i.p. implanted osmotic pumps reduced food intake similarly on experimental day 1, regardless of the genotype. After day 3, the lean rats' anorectic response and recovery were dose-dependent, whereas the anorectic response in obese rats was minimally affected by dose (significant dose effect only on day 3). Again, obese rats regained lost BW faster than lean rats. These results do not support a role for leptin as the sole mediator of anorexia induced by bacterial products (LPS and MDP) and IL-1β.

AB - To investigate the possible involvement of leptin signaling in lipopolysaccharide (LPS) anorexia, we compared the anorectic effect of LPS in genetically obese (fa/fa) Zucker rats and in their lean (Fa/?) counterparts. The effects of interleukin-1β (IL-1β) and muramyl dipeptide (MDP) were also tested. LPS [100 μg/kg body weight (BW)], IL-1β (2 μg/kg BW) and MDP (2.2 mg/kg BW) injected intraperitoneally (i.p.) at lights out reduced food intake similarly in obese and lean rats. LPS injection at 500 or 1000 μg/kg BW (i.p.) also reduced food intake and BW similarly in obese and lean rats, but obese regained BW faster than lean rats. LPS (2.45 μg or 9.8 μg/h/rat) administered chronically with i.p. implanted osmotic pumps reduced food intake similarly on experimental day 1, regardless of the genotype. After day 3, the lean rats' anorectic response and recovery were dose-dependent, whereas the anorectic response in obese rats was minimally affected by dose (significant dose effect only on day 3). Again, obese rats regained lost BW faster than lean rats. These results do not support a role for leptin as the sole mediator of anorexia induced by bacterial products (LPS and MDP) and IL-1β.

KW - Anorexia

KW - Body weight

KW - Cytokines

KW - Feeding

KW - Food intake

KW - Genotype

KW - Interleukin

KW - Leptin

KW - Obesity

UR - http://www.scopus.com/inward/record.url?scp=11844271446&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=11844271446&partnerID=8YFLogxK

U2 - 10.1016/j.physbeh.2004.11.003

DO - 10.1016/j.physbeh.2004.11.003

M3 - Article

C2 - 15642620

AN - SCOPUS:11844271446

VL - 84

SP - 165

EP - 173

JO - Physiology and Behavior

JF - Physiology and Behavior

SN - 0031-9384

IS - 1

ER -